NES
TEVA icon

New England Securities’s Teva Pharmaceuticals TEVA Stock Holding History

New England Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$253K Buy
4,407
+2,276
+107% +$127K 0.09% 230
2014
Q3 		$115K Buy
2,131
+142
+7% +$7.52K 0.04% 385
2014
Q2 		$104K Buy
1,989
+106
+6% +$5.42K 0.04% 438
2014
Q1 		$100K Buy
1,883
+326
+21% +$15.1K 0.04% 391
2013
Q4 		$62K Sell
1,557
-414
-21% -$16.3K 0.03% 491
2013
Q3 		$74K Buy
1,971
+413
+27% +$16.1K 0.04% 419
2013
Q2 		$61K Buy
+1,558
New +$60.7K 0.04% 386

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

New England Securities's TEVA Position: Q4 2014 in Review

New England Securities increased its Teva Pharmaceuticals (TEVA) stake by 107% in Q4 2014, buying an estimated $127K and bringing the position to 4,407 shares worth $253K. The position accounts for 0.09% of the portfolio, ranked #230.

New England Securities first reported a position in TEVA in Q2 2013 and has held it in 7 quarters since. 821 funds tracked by Wall St. Rank hold TEVA as of Q4 2014.

  • New England Securities held 4,407 shares of Teva Pharmaceuticals worth $253K as of Q4 2014.
  • New England Securities bought 2,276 Teva Pharmaceuticals shares in Q4 2014, an estimated $127K.
  • Teva Pharmaceuticals made up 0.09% of New England Securities's portfolio in Q4 2014, its #230 holding.
  • New England Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.